Prof. Swarnlata Saraf
'%3e%3cpath%20d='M22.1642%2019.0924C21.7317%2018.068%2021.1041%2017.1375%2020.3163%2016.3527C19.5309%2015.5656%2018.6006%2014.9381%2017.5766%2014.5048C17.5674%2014.5002%2017.5582%2014.4979%2017.5491%2014.4933C18.9774%2013.4616%2019.9059%2011.7811%2019.9059%209.88504C19.9059%206.74408%2017.3611%204.19922%2014.2201%204.19922C11.0792%204.19922%208.53429%206.74408%208.53429%209.88504C8.53429%2011.7811%209.46282%2013.4616%2010.8912%2014.4956C10.882%2014.5002%2010.8728%2014.5025%2010.8636%2014.5071C9.83652%2014.9404%208.91487%2015.5617%208.1239%2016.355C7.33685%2017.1404%206.70933%2018.0707%206.276%2019.0947C5.85031%2020.0972%205.62072%2021.172%205.59967%2022.2609C5.59905%2022.2853%205.60335%2022.3097%205.61229%2022.3325C5.62123%2022.3553%205.63465%2022.376%205.65174%2022.3935C5.66883%2022.4111%205.68926%2022.425%205.71182%2022.4345C5.73437%2022.444%205.7586%2022.4489%205.78308%2022.4489H7.15868C7.25956%2022.4489%207.3398%2022.3686%207.3421%2022.2701C7.38795%2020.5001%208.09868%2018.8425%209.35506%2017.5861C10.655%2016.2862%2012.3814%2015.5709%2014.2201%2015.5709C16.0588%2015.5709%2017.7852%2016.2862%2019.0852%2017.5861C20.3415%2018.8425%2021.0523%2020.5001%2021.0981%2022.2701C21.1004%2022.3709%2021.1807%2022.4489%2021.2815%2022.4489H22.6571C22.6816%2022.4489%2022.7058%2022.444%2022.7284%2022.4345C22.751%2022.425%2022.7714%2022.4111%2022.7885%2022.3935C22.8056%2022.376%2022.819%2022.3553%2022.8279%2022.3325C22.8369%2022.3097%2022.8412%2022.2853%2022.8406%2022.2609C22.8176%2021.165%2022.5907%2020.0989%2022.1642%2019.0924ZM14.2201%2013.8284C13.1678%2013.8284%2012.1773%2013.418%2011.4322%2012.6729C10.6871%2011.9278%2010.2767%2010.9374%2010.2767%209.88504C10.2767%208.83271%2010.6871%207.84227%2011.4322%207.09715C12.1773%206.35204%2013.1678%205.94165%2014.2201%205.94165C15.2724%205.94165%2016.2629%206.35204%2017.008%207.09715C17.7531%207.84227%2018.1635%208.83271%2018.1635%209.88504C18.1635%2010.9374%2017.7531%2011.9278%2017.008%2012.6729C16.2629%2013.418%2015.2724%2013.8284%2014.2201%2013.8284Z'%20fill='%238590A2'/%3e%3c/g%3e%3c/svg%3e)
Co-authors
Following
Followers
Research Focus & Metrics
Explore full metrics on Scilit
Academic Career Length
18Years (2009-Present)
(Calculated once Scilit publication data is synced: current year − year of first publication + 1)
Representative Publications
View All Publications1 July 2018 in Journal of Controlled Release
Journal Article
MAMukta Agrawal
Mukta Agrawal
Swarnlata SarafSSShailendra Saraf
Shailendra Saraf
Sophia G. AntimisiarisMCMahavir Bhupal Chougule
Mahavir Bhupal Chougule
AAAmit Alexander
Amit Alexander +1
1 May 2020 in Journal of Controlled Release
Journal Article
MAMukta Agrawal
Mukta Agrawal
Swarnlata SarafSSShailendra Saraf
Shailendra SarafSDSunil Kumar Dubey
Sunil Kumar Dubey
APAnu Puri
Anu PuriAAAmit Alexander
Amit Alexander +4
4 March 2009 in Journal of Diabetes
Journal Article
SJShelesh Jain
Shelesh Jain
Swarnlata Saraf30 December 2022 in Journal of Ravishankar University (PART-B)
Journal Article
TKTaranjeet Kukreja
Taranjeet Kukreja
Swarnlata SarafItraconazole is a triazole antifungal agent that is synthesised. Itraconazole has been manufactured into a variety of pharmacological formulations and administered by a variety of ways. Itraconazole pills are used to treat pulmonary fungal infections that can spread throughout the body. Because Itraconazole is not yet officially listed in any pharmacopoeia, only a few procedures for quality control and stability testing in pharmaceutical formulations have been published. The development of itraconazole-loaded nanostructured lipid carriers (ITZ-NLC). Itraconazole NLC have been successfully developed. Itraconazole topical NLC developed for the treatment of onychomycosis does not exist, according to my survey.The development and evaluation of stable itraconazole topical gel formulations proved successful. Itraconazole NLC was produced utilising the microemulsion method, indicating the viability of adopting this method as a continuous manufacturing tool for NLC formulation. Further, the ITZ- NLC was incorporated in the gelling agent and we evaluated it under specific parameters.
30 December 2022 in Journal of Ravishankar University (PART-B)
Journal Article
TKTaranjeet Kukreja
Taranjeet Kukreja
Swarnlata SarafItraconazole is a triazole antifungal agent that is synthesised. Itraconazole has been manufactured into a variety of pharmacological formulations and administered in a variety of ways. Itraconazole pills are used to treat pulmonary fungi that can cause fungal infection and spread throughout the body. Because Itraconazole is not yet officially listed in any pharmacopoeia, only a few procedures for quality control and stability testing in pharmaceutical formulations have been published. The goal of this study is to develop a more precise, easy, and cost-effective spectrophotometric approach for analysing Itraconazole in bulk and capsule dosage forms with improved precision, accuracy, and sensitivity. The UV spectroscopic determination was performed with Chloroform as the solvent at an absorption maximum of 267 nm. Linearity over the concentration range in the UV spectroscopic approach. The linearity of Itraconazole over the concentration range was found to be 1-10 g/ml using the UV spectroscopic technique, with a correlation coefficient of 0.999. The findings of the analyses were statistically and the recovery studies have confirmed this.
1 October 2023 in Current Traditional Medicine
Journal Article
In this modern era, medicinal plants and their phytoconstituents have received keen attention from researchers due to the various therapeutic implication found in different pharmacological investigations. Among millions of medicinal plants, Gloriosa superba is one of the therapeutically important ornamental climbers that has been traditionally used to cure several diseases such as intestinal worms, skin ailments, and joint pain. Researched data also indicated that the active principle of Gloriosa superba can produce significant therapeutic action by affecting specific pathophysiological targets of various ailments. In the last few years, its Crude extract, isolated active principles, and novel formulations have been claimed for several pharmacological activities such as antidiabetic, hepatoprotective, anticancer, antimicrobial, anthelmintic, antivenom, analgesic, antiarthritic, etc. The outcome of pharmacological research confirmed that this herb might be a source of precious phytochemicals to combat Enigmatic diseases such as cancers, and autoimmune diseases. The present article gathered the detailed pharmacological explorations on Gloriosa superba to contribute to the development of strategies for effective delivery of its Phytoconstituents to cure critical diseases.
About Me
Prof. Swarnlata Saraf graduated from the Indian Institute of Technology, BHU, Varanasi, and received her Ph.D. from Dr. H. S. Gour University Sagar, India. She guided 40 Master’s Degrees and 19 Ph.D. students. She wrote20 books & numerous chapters in edited books, filed/GRANTED patents, and contributed over 250 scientific publications. She served as an expert on national and international research projects & screening committees. According to Google Scholar, she has 12030 citations, an H-index of 52, and an i-10 index of 137,SCOPUS H-index 48 and has received national awards from various professional/statutary bodies. She handled research projects funded by national public agencies (India.she is consistently maintained the place since decade in scientist word ranking under 2% scientist by Stanford University,. Her area of interest is pharmaceutics, nanotechnology, herbal drug delivery, and cosmetic technology. She has widely travelled abroad, the USA, UK, Switzerland, Singapore, UAE, and many more for official, professional, and academic activities.Her Administrative credits in different bodies;
National: Regulatory Body: PCI ,NEW DELHI;Statutory body:;UGC,DST,AICTE;Accreditation body: NAAC-SWG,NBA, ;INI: Expert Member: nit-senate, niper-apdc, consultant-skills, NITTTR-);Technology transferred- 02 (reli-pile forte, pile cream)Industry experiences: SSPL-KOLKATA, SWASTIK PHARMACEUTICALS-International : ISRAEL SCIENCE FOUNDATION, AAPS-USA, ACPE-USA,SPDS-DRPI-USA.